TL;DR: Sialidosis is a rare, progressive lysosomal storage disorder caused by a deficiency of the enzyme neuraminidase, leading to the toxic buildup of sialylated compounds in body tissues. This condition affects multiple systems, including the nervous system and vision, and is classified into two main clinical types based on the age of onset and the severity of symptoms. What is the underlying cause of Sialidosis? Sialidosis occurs due to mutations in the NEU1 gene, which prevent the body from producing enough functional neuraminidase enzyme. Without this enzyme, complex sugars and proteins that should be broken down accumulate inside lysosomes—the "recycling centers" of cells. This buildup leads to cellular dysfunction, particularly in the central nervous system, eyes, and bones. Sialidosis is inherited in an autosomal recessive pattern, meaning an individual must inherit one defective gene copy from each parent to manifest the disease. How is Sialidosis classified? Medical experts generally categorize Sialidosis into two clinical forms based on the progression of the disease: Type I (Normosomatic): Typically presents in the second or third decade of life. It is characterized by vision loss (cherry-red spot in the macula) and involuntary muscle twitching (myoclonus). Type II (Dysmorphic): Usually presents in infancy or childhood. It is more severe and often involves skeletal abnormalities, enlarged liver or spleen, and intellectual disability. Which body systems are affected by Sialidosis? The progression of Sialidosis can impact various physiological systems. Common clinical features reported by the 13 members of the DiseaseMaps.org community and clinical literature include: Neurological: Progressive myoclonus, ataxia, and seizures. Ocular: Macular cherry-red spots and decreased visual acuity. Skeletal: Dysostosis multiplex (abnormal bone development) and shortened stature. How rare is Sialidosis? Sialidosis is an extremely rare condition with an estimated prevalence of less than 1 in 1,000,000 worldwide. Because it is so rare, it is often underdiagnosed or misdiagnosed. It affects both males and females equally and has been identified in diverse populations across the globe. Next steps Consult a metabolic specialist or clinical geneticist to discuss diagnostic enzyme assays or genetic testing. Connect with the 13 members of the Sialidosis community at DiseaseMaps.org to share experiences and coping strategies. Maintain regular follow-ups with ophthalmologists and neurologists to manage symptom progression. Medical disclaimer: This content is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. References NIH Genetic and Rare Diseases Information Center (GARD): Sialidosis. Orphanet: Sialidosis (ORPHA:3145). OMIM (Online Mendelian Inheritance in Man): Sialidosis, Type I and Type II (#256550).

Short answer · Medically reviewed summary · Last updated: 2026-05-08

TL;DR: Sialidosis is a rare, progressive lysosomal storage disorder caused by a deficiency of the enzyme neuraminidase, leading to the toxic buildup of sialylated compounds in body tissues. This condition affects multiple systems, including the nervous system and vision, and is classified into two main clinical types based on the age of onset and the severity of symptoms. What is the underlying cause of Sialidosis? Sialidosis occurs due to mutations in the NEU1 gene, which prevent the body from producing enough functional neuraminidase enzyme.

What is Sialidosis

Name: What is Sialidosis
Creator: DiseaseMaps Editorial Team
Published: 2016-10-21UTC04:29:19.0000000

What is Sialidosis? Plain-language, medically reviewed definition plus the lived reality told by patients.

TL;DR: Sialidosis is a rare, progressive lysosomal storage disorder caused by a deficiency of the enzyme neuraminidase, leading to the toxic buildup of sialylated compounds in body tissues. This condition affects multiple systems, including the nervous system and vision, and is classified into two main clinical types based on the age of onset and the severity of symptoms.

What is the underlying cause of Sialidosis?

Sialidosis occurs due to mutations in the NEU1 gene, which prevent the body from producing enough functional neuraminidase enzyme. Without this enzyme, complex sugars and proteins that should be broken down accumulate inside lysosomes—the "recycling centers" of cells. This buildup leads to cellular dysfunction, particularly in the central nervous system, eyes, and bones. Sialidosis is inherited in an autosomal recessive pattern, meaning an individual must inherit one defective gene copy from each parent to manifest the disease.

How is Sialidosis classified?

Medical experts generally categorize Sialidosis into two clinical forms based on the progression of the disease:

Type I (Normosomatic): Typically presents in the second or third decade of life. It is characterized by vision loss (cherry-red spot in the macula) and involuntary muscle twitching (myoclonus).

Type II (Dysmorphic): Usually presents in infancy or childhood. It is more severe and often involves skeletal abnormalities, enlarged liver or spleen, and intellectual disability.

Which body systems are affected by Sialidosis?

The progression of Sialidosis can impact various physiological systems. Common clinical features reported by the 13 members of the DiseaseMaps.org community and clinical literature include:

Neurological: Progressive myoclonus, ataxia, and seizures.

Ocular: Macular cherry-red spots and decreased visual acuity.

Skeletal: Dysostosis multiplex (abnormal bone development) and shortened stature.

How rare is Sialidosis?

Sialidosis is an extremely rare condition with an estimated prevalence of less than 1 in 1,000,000 worldwide. Because it is so rare, it is often underdiagnosed or misdiagnosed. It affects both males and females equally and has been identified in diverse populations across the globe.

Next steps

Consult a metabolic specialist or clinical geneticist to discuss diagnostic enzyme assays or genetic testing.

Connect with the 13 members of the Sialidosis community at DiseaseMaps.org to share experiences and coping strategies.

Maintain regular follow-ups with ophthalmologists and neurologists to manage symptom progression.

Medical disclaimer: This content is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.